HansBiomed Corporation (KOSDAQ:042520)
South Korea · Delayed Price · Currency is KRW 29,850
-2,150 (-6.72%)
At close: Apr 9, 2026
HansBiomed Market Cap
HansBiomed has a market cap or net worth of 425.7 billion as of April 10, 2026. Its market cap has increased by 343.56% in one year.
Market Cap
425.70B
Enterprise Value
452.94B
Revenue
100.17B
Ranking
n/a
PE Ratio
n/a
Stock Price
29,850.00
Market Cap Chart
Since October 9, 2009, HansBiomed's market cap has increased from 49.00B to 425.70B, an increase of 768.69%. That is a compound annual growth rate of 13.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 9, 2026 | 425.70B | 12.69% |
| Dec 30, 2025 | 377.76B | 229.79% |
| Dec 30, 2024 | 114.55B | -39.92% |
| Dec 28, 2023 | 190.65B | 100.91% |
| Dec 29, 2022 | 94.89B | -16.49% |
| Dec 30, 2021 | 113.63B | -16.24% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Curocell | 813.61B |
| IMBiologics | 746.91B |
| IntoCell | 593.37B |
| Kanaph Therapeutics | 466.42B |
| Y-Biologics | 374.14B |
| S.Biomedics | 329.44B |
| Kangstem Biotech | 303.79B |
| TiumBio | 302.41B |